BusinessTelix Pharmaceuticals Limited Launches $50 Million Underwritten Initial Public Offering (ASX: TLX)By Nasdaq OMXOct 23, 2017, 9:00 PM UTC
BusinessEarth Science Tech Strengthens Advisory Board with Four Distinguished Scientists and Doctors to Expand the Pharmaceutical & Nutraceutical Development of Cannabinoids' Therapeutic Indications, R&D, Technology, IP and TreatmentsBy Nasdaq OMXFeb 9, 2017, 12:45 PM UTC
